Literature DB >> 1972176

A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.

M Suthanthiran1.   

Abstract

Transmembrane signaling of normal human T cells was explored with mAbs directed at TCR, CD2, CD4, CD5, or CD8 antigens and highly purified CD4+ T cells and CD8+ T cells. Our experiments explicitly show that: (a) crosslinkage of TCR with the CD2 antigen, and not independent crosslinking of TCR and of CD2 antigen or crosslinking of either protein with the CD4 or CD8 antigen induces significant proliferation independent of co-stimulatory signals (e.g., accessory cells, recombinant lymphokines, or tumor promoter), (b) F(ab')2 fragments of mAb directed at the TCR and F(ab')2 anti-CD2, crosslinked with F(ab')2 fragments of rabbit anti-mouse IgG, promote the proliferation of highly purified T cells, (c) a prompt and sustained increase in intracellular free Ca2+ concentration results from crosslinkage of TCR with the CD2 antigen, (d) T cell proliferation induced by this novel approach is curtailed by EGTA and by direct or competitive inhibitors of PKC, (e) crosslinkage of TCR with the CD2 antigen results in the transcriptional activation and translation of the gene for IL-2 and in the expression of IL-2 receptor alpha (CD25), (f) anti-CD25 mAbs inhibit T cell proliferation initiated by crosslinkage of TCR with the CD2 antigen, and recombinant IL-2 restores the proliferative response. Our first demonstration that crosslinkage of TCR with the CD2 antigen induces proliferation of normal human CD4+ T cells and CD8+ T cells, in addition to revealing a novel activation mechanism utilizable by the two major subsets of T cells, suggest that the CD2 antigen might be targeted for the regulation of antigen-specific T cell immunity (e.g., organ transplantation).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972176      PMCID: PMC2187964          DOI: 10.1084/jem.171.6.1965

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  45 in total

1.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

2.  An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein.

Authors:  S C Meuer; R E Hussey; M Fabbi; D Fox; O Acuto; K A Fitzgerald; J C Hodgdon; J P Protentis; S F Schlossman; E L Reinherz
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

3.  Suppression of human T-cell mitogenesis and E-rosette formation by the monoclonal antibody OKT11A.

Authors:  J Van Wauwe; J Goossens; W Decock; P Kung; G Goldstein
Journal:  Immunology       Date:  1981-12       Impact factor: 7.397

4.  Is the E receptor on human T lymphocytes a "negative signal receptor"?

Authors:  R Palacios; O Martinez-Maza
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

5.  Monoclonal antibodies OKT 11 and OKT 11A have pan-T reactivity and block sheep erythrocyte "receptors".

Authors:  W Verbi; M F Greaves; C Schneider; K Koubek; G Janossy; H Stein; P Kung; G Goldstein
Journal:  Eur J Immunol       Date:  1982-01       Impact factor: 5.532

6.  Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3.

Authors:  F Sanchez-Madrid; A M Krensky; C F Ware; E Robbins; J L Strominger; S J Burakoff; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  Free cytoplasmic calcium concentration and the mitogenic stimulation of lymphocytes.

Authors:  T R Hesketh; G A Smith; J P Moore; M V Taylor; J C Metcalfe
Journal:  J Biol Chem       Date:  1983-04-25       Impact factor: 5.157

8.  Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor.

Authors:  S C Meuer; O Acuto; R E Hussey; J C Hodgdon; K A Fitzgerald; S F Schlossman; E L Reinherz
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

9.  Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells.

Authors:  W J Tax; H W Willems; P P Reekers; P J Capel; R A Koene
Journal:  Nature       Date:  1983 Aug 4-10       Impact factor: 49.962

10.  Evidence for an interleukin-independent pathway for human lymphocyte activation.

Authors:  G A Koretzky; R P Daniele; W C Greene; P C Nowell
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  6 in total

1.  CD3 and CD2 antigen-mediated CD3 gamma-chain phosphorylation in permeabilized human T cells. Regulation by cytosolic phosphatases.

Authors:  D R Alexander; M H Brown; A L Tutt; M J Crumpton; E Shivnan
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

Review 2.  Immunosuppressive drug therapy.

Authors:  Choli Hartono; Thangamani Muthukumar; Manikkam Suthanthiran
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

Review 3.  Immunobiology and immunopharmacology of organ allograft rejection.

Authors:  M Suthanthiran; T B Strom
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

4.  Urinary cell transcriptomics and acute rejection in human kidney allografts.

Authors:  Akanksha Verma; Thangamani Muthukumar; Hua Yang; Michelle Lubetzky; Michael F Cassidy; John R Lee; Darshana M Dadhania; Catherine Snopkowski; Divya Shankaranarayanan; Steven P Salvatore; Vijay K Sharma; Jenny Z Xiang; Iwijn De Vlaminck; Surya V Seshan; Franco B Mueller; Karsten Suhre; Olivier Elemento; Manikkam Suthanthiran
Journal:  JCI Insight       Date:  2020-02-27

5.  The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.

Authors:  J W Young; L Koulova; S A Soergel; E A Clark; R M Steinman; B Dupont
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

6.  Anti-CD2 antibodies induce T cell unresponsiveness in vivo.

Authors:  B Gückel; C Berek; M Lutz; P Altevogt; V Schirrmacher; B A Kyewski
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.